在SLE中B细胞耐受性和向疗法
Ioannis Parodis1,2,3, Xuan Long4, Mikael C I Karlsson5
1Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, 17177 Stockholm, Sweden.
Journal of clinical medicine
|October 14, 2023
概括
系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,由B细胞功能障碍驱动. 本综述探讨了B细胞生物学,免疫相互作用以及针对SLE的向治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 这是一种自身免疫力.
- 类风湿病学 类风湿病学
背景情况:
- 系统性红斑狼 (SLE) 是一种异质的自身免疫性疾病,其特征是免疫系统失调.
- B细胞过度活跃和自身抗体的产生是SLE病原体的核心.
- 在SLE中,先天性和适应性免疫之间的复杂相互作用仍然不完全理解.
研究的目的:
- 审查当前关于B细胞发育,耐受性和SLE中的功能知识.
- 讨论各种免疫细胞对B细胞的调节.
- 检查针对B细胞的治疗方法和未来的研究方向.
主要方法:
- 关于B细胞生物学和SLE最近进展的文献综述.
- 在狼自身免疫的背景下对免疫细胞相互作用的分析.
- 综合有关当前和新兴治疗策略的信息.
主要成果:
- 在SLE中,B细胞的发育,成熟和耐受机制至关重要.
- T细胞,粒细胞和其他免疫细胞对B细胞的失调有助于SLE.
- 效应体B细胞在SLE病理生理学中起着重要作用.
结论:
- 了解B细胞生物学是解开SLE病变的关键.
- 向B细胞为SLE治疗提供了有前途的治疗途径.
- 对免疫细胞相互作用的进一步研究将指导未来的SLE管理策略.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Special Features of Adaptive Immunity
841
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
841
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
150
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
150
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K


